PMU18 Budget IMPACT Analysis of the Eluvia Drug-Eluting Stent for Peripheral Artery Disease in Korea

Abstract

was rarely performed. Conclusions: The number of recommended HTAPs to set up a reimbursement fee for a procedure in Japan has grown steadily. However, the applications that didn't satisfy criteria for discussion have also increased. Therefore, applicants should consider providing more evidence to demonstrate improved outcomes with the new procedure to enable a successful recommendation by the Health Technology Assessment Sub-committee.